Yunze Xu

657 total citations
29 papers, 456 citations indexed

About

Yunze Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yunze Xu has authored 29 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yunze Xu's work include Cancer, Hypoxia, and Metabolism (11 papers), Renal cell carcinoma treatment (7 papers) and ATP Synthase and ATPases Research (5 papers). Yunze Xu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Renal cell carcinoma treatment (7 papers) and ATP Synthase and ATPases Research (5 papers). Yunze Xu collaborates with scholars based in China, Australia and Canada. Yunze Xu's co-authors include Yong Huang, Wei Xue, Wen Kong, Baijun Dong, Yicheng Qi, Guang Ning, Yu Zhu, Jin Zhang, Zhoujun Shen and Yongning Lu and has published in prestigious journals such as PLoS ONE, Radiology and Annals of Oncology.

In The Last Decade

Yunze Xu

28 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yunze Xu China 12 188 152 150 106 97 29 456
Judy L. Shih United States 9 179 1.0× 137 0.9× 242 1.6× 97 0.9× 223 2.3× 11 612
Jarkko Soronen Finland 12 314 1.7× 175 1.2× 98 0.7× 27 0.3× 109 1.1× 15 652
Leandro M. Colli Brazil 15 264 1.4× 139 0.9× 144 1.0× 95 0.9× 257 2.6× 35 689
Lorena Blanco Spain 13 162 0.9× 95 0.6× 84 0.6× 92 0.9× 85 0.9× 23 450
Linda W.C. Ng Hong Kong 9 107 0.6× 181 1.2× 241 1.6× 45 0.4× 138 1.4× 11 452
Sven Hauke Germany 12 235 1.3× 82 0.5× 47 0.3× 91 0.9× 62 0.6× 17 563
Antonio C. Fuentes-Fayos Spain 14 335 1.8× 163 1.1× 54 0.4× 79 0.7× 109 1.1× 34 547
Hajime Kanauchi Japan 12 200 1.1× 85 0.6× 95 0.6× 56 0.5× 128 1.3× 25 529
Masahiro Shiba Japan 10 181 1.0× 88 0.6× 55 0.4× 65 0.6× 22 0.2× 37 448

Countries citing papers authored by Yunze Xu

Since Specialization
Citations

This map shows the geographic impact of Yunze Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunze Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunze Xu more than expected).

Fields of papers citing papers by Yunze Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunze Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunze Xu. The network helps show where Yunze Xu may publish in the future.

Co-authorship network of co-authors of Yunze Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yunze Xu. A scholar is included among the top collaborators of Yunze Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunze Xu. Yunze Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Jiwei, Jianfeng Wang, Ge Li, et al.. (2024). Fumarate induces LncRNA-MIR4435-2HG to regulate glutamine metabolism remodeling and promote the development of FH-deficient renal cell carcinoma. Cell Death and Disease. 15(2). 151–151. 5 indexed citations
2.
Yang, Xiaoqun, Yang Liu, Huafeng Wang, et al.. (2024). Fumarate Hydratase–Deficient Renal Cell Carcinoma With Predominant Tubulocystic Features Mimics Tubulocystic Renal Cell Carcinoma. Archives of Pathology & Laboratory Medicine. 148(12). 1358–1364. 2 indexed citations
3.
Wang, Jiaojian, Meng Yang, Cheng Hu, et al.. (2023). Predictive value of total ischaemic time and T1 mapping after emergency percutaneous coronary intervention in acute ST-segment elevation myocardial infarction. Clinical Radiology. 78(10). e724–e731. 2 indexed citations
4.
5.
Wu, Guangyu, Jianfeng Wang, Yunze Xu, et al.. (2022). MR Spectroscopy for Detecting Fumarate Hydratase Deficiency in Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome. Radiology. 305(3). 631–639. 4 indexed citations
6.
7.
Yin, Xiaomao, et al.. (2021). Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma. OncoImmunology. 10(1). 1933332–1933332. 37 indexed citations
8.
Wang, Xiaojing, Xiaoxia Li, Meng Li, et al.. (2019). Apogossypolone acts as a metastasis inhibitor via up-regulation of E-cadherin dependent on the GSK-3/AKT complex.. Europe PMC (PubMed Central). 11(1). 218–232. 5 indexed citations
9.
Lu, Yongning, Baijun Dong, Fan Xu, et al.. (2019). CXCL1-LCN2 paracrine axis promotes progression of prostate cancer via the Src activation and epithelial-mesenchymal transition. Cell Communication and Signaling. 17(1). 118–118. 68 indexed citations
10.
Xu, Yunze, et al.. (2017). NVP-AUY922, a novel HSP90 inhibitor, inhibits the progression of malignant pheochromocytoma in vitro and in vivo. OncoTargets and Therapy. Volume 10. 2219–2226. 10 indexed citations
11.
Li, Meng, Feifei Xu, Yunze Xu, et al.. (2017). Enhanced wild-type p53 expression by small activating RNA dsP53-285 induces cell cycle arrest and apoptosis in pheochromocytoma cell line PC12. Oncology Reports. 38(5). 3160–3166. 7 indexed citations
12.
Li, Xiaoxia, Yunze Xu, Meng Li, et al.. (2017). Apogossypolone (ApoG2) induces ROS-dependent apoptosis and reduces invasiveness of PC12 cells in vitro and in vivo.. PubMed. 9(9). 3990–4002. 6 indexed citations
13.
Wang, Jianfeng, Yunze Xu, Yun Zou, et al.. (2017). Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression. Journal of Cancer Research and Clinical Oncology. 144(1). 39–52. 25 indexed citations
14.
Wang, Jianfeng, Yunze Xu, Yun Zou, et al.. (2016). Overexpression of cannabinoid receptor 1 promotes renal cell carcinoma progression. Tumor Biology. 37(12). 16237–16247. 10 indexed citations
15.
Wang, Jianfeng, Yunze Xu, Yun Zou, et al.. (2016). High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma. PLoS ONE. 11(11). e0166231–e0166231. 36 indexed citations
16.
Xu, Yunze, Qi Zhu, Dongning Chen, et al.. (2015). The HSP90 inhibitor 17-AAG exhibits potent antitumor activity for pheochromocytoma in a xenograft model. Tumor Biology. 36(7). 5103–5108. 8 indexed citations
17.
Xu, Yunze, Yicheng Qi, Jin Zhang, et al.. (2014). The impact of smoking on survival in renal cell carcinoma: a systematic review and meta-analysis. Tumor Biology. 35(7). 6633–6640. 18 indexed citations
18.
Zhang, Chongyu, Yunze Xu, Dongning Chen, et al.. (2013). Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation. Tumor Biology. 34(6). 4065–4071. 7 indexed citations
19.
Xu, Yunze, Yicheng Qi, Wenbin Rui, et al.. (2013). Expression and diagnostic relevance of heat shock protein 90 and signal transducer and activator of transcription 3 in malignant pheochromocytoma. Journal of Clinical Pathology. 66(4). 286–290. 8 indexed citations
20.
Xu, Yunze, Yu Zhu, Zhoujun Shen, et al.. (2011). Significance of heparanase-1 and vascular endothelial growth factor in adrenocortical carcinoma angiogenesis: potential for therapy. Endocrine. 40(3). 445–451. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judy L. Shih Breakdown of academic impact, for papers by Jarkko Soronen Breakdown of academic impact, for papers by Leandro M. Colli Breakdown of academic impact, for papers by Lorena Blanco Breakdown of academic impact, for papers by Linda W.C. Ng Breakdown of academic impact, for papers by Sven Hauke Breakdown of academic impact, for papers by Antonio C. Fuentes-Fayos Breakdown of academic impact, for papers by Hajime Kanauchi Breakdown of academic impact, for papers by Masahiro Shiba
Rankless by CCL
2026